Prof. Florent Malard, Hôpital Saint-Antoine, Paris, France
Prof. Malard discussed the latest evidence and translational prospects of microbiota modulation in preventing and treating transplant-related complications such as acute graft-versus-host disease (aGVHD) and infections in HSCT. He also explored how the gut-immune axis can help optimize peri-transplant supportive care and improve long-term patient outcomes.